| Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 … VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ... The lancet Respiratory medicine 9 (12), 1407-1418, 2021 | 682 | 2021 |
| Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised … P Nash, B Kirkham, M Okada, P Rahman, B Combe, GR Burmester, ... The Lancet 389 (10086), 2317-2327, 2017 | 446 | 2017 |
| Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors SS Newton, EF Collier, J Hunsberger, D Adams, R Terwilliger, ... Journal of Neuroscience 23 (34), 10841-10851, 2003 | 439 | 2003 |
| Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological … D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ... The Lancet 392 (10163), 2441-2451, 2018 | 362 | 2018 |
| Volume I. introduction to DUNE B Abi, R Acciarri, MA Acero, G Adamov, D Adams, M Adinolfi, Z Ahmad, ... Journal of instrumentation 15 (08), T08008, 2020 | 359 | 2020 |
| A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression EB Brown, SL McElroy, PE Keck Jr, A Deldar, DH Adams, M Tohen, ... Journal of Clinical Psychiatry 67 (7), 1025-1033, 2006 | 251 | 2006 |
| Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial A Deodhar, D van der Heijde, LS Gensler, TH Kim, WP Maksymowych, ... The Lancet 395 (10217), 53-64, 2020 | 220 | 2020 |
| Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs H Liu-Seifert, DH Adams, BJ Kinon BMC medicine 3, 1-10, 2005 | 215 | 2005 |
| The DUNE far detector interim design report volume 1: physics, technology and strategies B Abi, R Acciarri, MA Acero, M Adamowski, C Adams, D Adams, ... arXiv preprint arXiv:1807.10334, 2018 | 208 | 2018 |
| Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. JP Lindenmayer, H Liu-Seifert, PM Kulkarni, BJ Kinon, V Stauffer, ... Journal of Clinical Psychiatry 70 (7), 990, 2009 | 202 | 2009 |
| Use of chemotherapy at end of life in oncology patients S Kao, J Shafiq, J Vardy, D Adams Annals of Oncology 20 (9), 1555-1559, 2009 | 184 | 2009 |
| Clinical practice recommendations for bipolar disorder GS Malhi, D Adams, L Lampe, M Paton, N O’connor, LA Newton, G Walter, ... Acta Psychiatrica Scandinavica 119, 27-46, 2009 | 168 | 2009 |
| Organic matter dynamics in soils of the tropics—from myth to complex reality DJ Greenland, A Wild, D Adams Myths and Science of Soils of the Tropics 29, 17-33, 1992 | 154 | 1992 |
| Goldbug: big seven open source crypto-messengers to be compared-or: comprehensive confidentiality review & audit of GoldBug: encrypting E-Mail-Client & secure instant messenger D Adams, AK Maier SourceForge Media, 2016 | 149 | 2016 |
| Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study BJ Kinon, J Volavka, V Stauffer, SE Edwards, H Liu-Seifert, L Chen, ... Journal of clinical psychopharmacology 28 (4), 392-400, 2008 | 140 | 2008 |
| Patient concerns about medical errors in emergency departments TE Burroughs, AD Waterman, TH Gallagher, B Waterman, D Adams, ... Academic Emergency Medicine 12 (1), 57-64, 2005 | 133 | 2005 |
| A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms BJ Kinon, I Lipkovich, SB Edwards, DH Adams, H Ascher-Svanum, ... Journal of clinical psychopharmacology 26 (2), 157-162, 2006 | 127 | 2006 |
| Clinical practice recommendations for depression GS Malhi, D Adams, R Porter, A Wignall, L Lampe, N O’connor, M Paton, ... Acta Psychiatrica Scandinavica 119, 8-26, 2009 | 125 | 2009 |
| Gene expression profiling in postmortem prefrontal cortex of major depressive disorder HJ Kang, DH Adams, A Simen, BB Simen, G Rajkowska, CA Stockmeier, ... Journal of Neuroscience 27 (48), 13329-13340, 2007 | 123 | 2007 |
| A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of … DH Adams, BJ Kinon, S Baygani, BA Millen, I Velona, S Kollack-Walker, ... BMC psychiatry 13, 1-9, 2013 | 120 | 2013 |
